Quick Answer
ACADIA PHARMACEUTICALS INC reported Net Income Loss of $391.00 million for the year ending 2025.
- ACADIA PHARMACEUTICALS INC showed an increase of +72.7% in Net Income Loss from 2024 to 2025.
- This data is from ACADIA PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), ACADIA PHARMACEUTICALS INC's Net Income Loss has grown by 966.1%.
- Historical annual values: Fiscal year 2025: $391.00 million | Fiscal year 2024: $226.45 million | Fiscal year 2023: -$61.29 million | Fiscal year 2022: -$215.98 million | Fiscal year 2021: -$167.87 million | Fiscal year 2020: -$281.58 million | Fiscal year 2019: -$235.26 million | Fiscal year 2018: -$245.19 million | Fiscal year 2017: -$289.40 million | Fiscal year 2016: -$271.39 million | Fiscal year 2015: -$164.44 million | Fiscal year 2014: -$92.48 million | Fiscal year 2013: -$37.95 million | Fiscal year 2012: -$20.85 million | Fiscal year 2011: -$22.77 million | Fiscal year 2010: $15.14 million | Fiscal year 2009: -$45.15 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: